Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Selinger

Showing results (841-850 of 895) with videos related to

Pageof 90
Sort By:
Journal of Crohn'S & Colitis|April 10, 2021
Dose optimisation for Loss of Response to Vedolizumab- Pharmacokinetics and Immune MechanismsBella Ungar, Karin Malickova, Jurij Hanžel, et al.
Annals of Human Genetics|June 21, 2001
Existence of a genetic risk factor on chromosome 5q in Italian coeliac disease familiesL Greco, M C Babron, G R Corazza, et al.
Frontline Gastroenterology|October 19, 2023
Opioid use and associated factors in 1676 patients with inflammatory bowel disease: a multicentre quality improvement projectSamantha Baillie, Jimmy K Limdi, Ash Bassi, et al.
The American Journal of Surgical Pathology|December 16, 2014
A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinomaAngela Chou, Sheila Fraser, Christopher W Toon, et al.
United European Gastroenterology Journal|October 5, 2024
Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspectiveTommaso Lorenzo Parigi, Virginia Solitano, Alessandro Armuzzi, et al.
Journal of General Internal Medicine|January 21, 2025
Medical Students' Observations of High Value and Potentially Wasteful Care Behaviors Modeled During Clinical RotationsAmanda Wade, Meher Kalkat, Colin Uyeki, et al.
Investigational New Drugs|May 11, 2002
Population pharmacokinetic and dynamic analysis of the topoisomerase I inhibitor lurtotecan in phase II studiesJ H M Schellens, B Heinrich, M Lehnert, et al.
Asia-Pacific Journal of Clinical Oncology|May 29, 2018
FISH analysis of selected soft tissue tumors: Diagnostic experience in a tertiary centerAna Cristina Vargas, Christina Selinger, Laveniya Satgunaseelan, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 6, 2018
A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine studyMarco Vincenzo Lenti, Scott Levison, Elena Eliadou, et al.
Alimentary Pharmacology & Therapeutics|September 19, 2018
The role of multimodal treatment in Crohn's disease patients with perianal fistula: a multicentre retrospective cohort studyShaji Sebastian, Christopher Black, Daniela Pugliese, et al.
Pageof 90

Showing results (841-850 of 895) with videos related to

Sort By:
Pageof 90
Journal of Crohn'S & Colitis|April 10, 2021
Dose optimisation for Loss of Response to Vedolizumab- Pharmacokinetics and Immune MechanismsBella Ungar, Karin Malickova, Jurij Hanžel, et al.
Annals of Human Genetics|June 21, 2001
Existence of a genetic risk factor on chromosome 5q in Italian coeliac disease familiesL Greco, M C Babron, G R Corazza, et al.
Frontline Gastroenterology|October 19, 2023
Opioid use and associated factors in 1676 patients with inflammatory bowel disease: a multicentre quality improvement projectSamantha Baillie, Jimmy K Limdi, Ash Bassi, et al.
The American Journal of Surgical Pathology|December 16, 2014
A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinomaAngela Chou, Sheila Fraser, Christopher W Toon, et al.
United European Gastroenterology Journal|October 5, 2024
Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspectiveTommaso Lorenzo Parigi, Virginia Solitano, Alessandro Armuzzi, et al.
Journal of General Internal Medicine|January 21, 2025
Medical Students' Observations of High Value and Potentially Wasteful Care Behaviors Modeled During Clinical RotationsAmanda Wade, Meher Kalkat, Colin Uyeki, et al.
Investigational New Drugs|May 11, 2002
Population pharmacokinetic and dynamic analysis of the topoisomerase I inhibitor lurtotecan in phase II studiesJ H M Schellens, B Heinrich, M Lehnert, et al.
Asia-Pacific Journal of Clinical Oncology|May 29, 2018
FISH analysis of selected soft tissue tumors: Diagnostic experience in a tertiary centerAna Cristina Vargas, Christina Selinger, Laveniya Satgunaseelan, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 6, 2018
A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine studyMarco Vincenzo Lenti, Scott Levison, Elena Eliadou, et al.
Alimentary Pharmacology & Therapeutics|September 19, 2018
The role of multimodal treatment in Crohn's disease patients with perianal fistula: a multicentre retrospective cohort studyShaji Sebastian, Christopher Black, Daniela Pugliese, et al.
Pageof 90